Skip to content
Markets News
Stocks1 min read

Merck Slips 2.66% as Major Indexes Post Mixed Results

Makkler Newsroom
September 30, 2026

The decline outpaced the S&P 500 as Merck’s October earnings report approaches, with consensus forecasts pointing to lower quarterly earnings.

Merck shares fell 2.66% to $145.31 in the latest session, underperforming the S&P 500, which lost 0.25%. The Dow fell 0.86%, while the Nasdaq rose 0.24%.

The decline came after Merck shares lost 0.39% over the prior month. The Medical sector fell 1.01% over that period, while the S&P 500 was down 0.42%. The report did not identify a company-specific catalyst for the latest drop.

Merck is scheduled to report earnings on October 29, 2026. Zacks consensus estimates project quarterly earnings of $2.25 per share, down 12.79% from the year-earlier quarter, and revenue of $17.52 billion, up 1.39%.

For the year, Zacks consensus estimates put earnings at $2.77 per share and revenue at $67.25 billion. Those figures represent a 69.15% decline in earnings and a 3.44% increase in revenue from the prior year. The consensus quarterly EPS estimate was revised 0.07% lower over the past month.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.